Compliance-ready documents, explained
Practical guides on 21 CFR Part 11, electronic signatures, audits and digital SOPs for pharma and life sciences teams.
Pharmaceutical
Pharma: Steps to Conduct a Self-Assessment for 21 CFR Part 11 Readiness
In the pharma industry, compliance with 21 CFR Part 11 is not optional—it’s a necessity. This regulation, established by the FDA, ensures that ele
Electronic Signature Contracts: Secure Storage & Retrieval
With businesses increasingly relying on Electronic Signature Contracts, securely storing and retrieving eSigned documents has become more important th
Pharma: Multi-Factor Authentication for 21 CFR Part 11 Compliance
Pharma companies operate in a highly regulated environment where data security and compliance are paramount. Ensuring compliance with 21 CFR Part 11 i
Electronic Signature Contracts: What FDA Requires
The shift from traditional wet signatures to electronic signatures (eSignatures) has transformed how businesses and regulated industries manage contra
e-Signature for Pharmaceutical: How Cloud-Based Digital Solutions Improve FDA Compliance
In the pharmaceutical industry, ensuring FDA compliance is non-negotiable. From clinical trials to vendor contracts, every process must adhere to stri
21 CFR Part 11 Compliance: Ensuring Data Integrity in FDA-Regulated Industries
In today’s digital era, maintaining data integrity is a top priority for FDA-regulated industries, particularly in pharmaceuticals, biotechnology, a
Subscribe to our newsletter
One email a month with new compliance guides, product releases and customer stories. No spam.
Unsubscribe any time.